Analystreport

REGENXBIO Inc. (NASDAQ: RGNX) had its price target lowered by analysts at Chardan Capital from $61.00 to $55.00.

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com